Biotin-functionalized nanoparticles: an overview of recent trends in cancer detection
Open Access
- 10 June 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (27) , 12750-12792
Abstract
Electrochemical bio-sensing is a potent and efficient method for converting various biological recognition events into voltage, current, and impedance electrical signals. Biochemical sensors are now a common part of medical applications, such as detecting blood glucose levels, detecting food pathogens, and detecting specific cancers. As an exciting feature, bio-affinity couples, such as proteins with aptamers, ligands, paired nucleotides, and antibodies with antigens, are commonly used as bio-sensitive elements in electrochemical biosensors. Biotin–avidin interactions have been utilized for various purposes in recent years, such as targeting drugs, diagnosing clinically, labeling immunologically, biotechnology, biomedical engineering, and separating or purifying biomolecular compounds. The interaction between biotin and avidin is widely regarded as one of the most robust and reliable noncovalent interactions due to its high bi-affinity and ability to remain selective and accurate under various reaction conditions and bio-molecular attachments. More recently, there have been numerous attempts to develop electrochemical sensors to sense circulating cancer cells and the measurement of intracellular levels of protein thiols, formaldehyde, vitamin-targeted polymers, huwentoxin-I, anti-human antibodies, and a variety of tumor markers (including alpha-fetoprotein, epidermal growth factor receptor, prostate-specific Ag, carcinoembryonic Ag, cancer antigen 125, cancer antigen 15-3, etc.). Still, the non-specific binding of biotin to endogenous biotin-binding proteins present in biological samples can result in false-positive signals and hinder the accurate detection of cancer biomarkers. This review summarizes various categories of biotin-functional nanoparticles designed to detect such biomarkers and highlights some challenges in using them as diagnostic tools.Keywords
Funding Information
- Agencia Estatal de Investigación (RYC2021-031003I)
- European Commission (NextGeneration EU RYC2021-031003I)
This publication has 249 references indexed in Scilit:
- Activity‐based Fluorescent Sensors and Their Applications in Biological Studies2022
- Antibody‐Incorporated Nanomedicines for Cancer TherapyAdvanced Materials, 2022
- Biomedical Micro‐/Nanomotors: From Overcoming Biological Barriers to In Vivo ImagingAdvanced Materials, 2020
- Smart Gold Nanostructures for Light Mediated Cancer Theranostics: Combining Optical Diagnostics with Photothermal TherapyAdvanced Science, 2020
- Recent Trends in Electrochemical Sensors for Vital Biomedical Markers Using Hybrid Nanostructured MaterialsAdvanced Science, 2020
- Surface Modification of Nanoparticles: Methods and Applications2019
- Tumor Targeting Strategies of Smart Fluorescent Nanoparticles and Their Applications in Cancer Diagnosis and TreatmentAdvanced Materials, 2019
- Current and Future Perspectives on Skin Tissue Engineering: Key Features of Biomedical Research, Translational Assessment, and Clinical ApplicationAdvanced Healthcare Materials, 2019
- An Activatable Theranostic for Targeted Cancer Therapy and ImagingAngewandte Chemie, 2014
- Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancerThe Journal of Pathology, 1998